A short clip weighing the approved tirzepatide against retatrutide, which is still in trials, for people over 50.
Recap by typeshit. Full story at Dr. Jones DC Clips.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
People on GLP-1 medicines reported nail issues, including nails separating from the skin, more often than non-users in a new survey.
NexLife put out a monthly index tracking what online sellers charge for compounded GLP-1 drugs. Only the announcement title is available so far.
Loading…